Four things to know:
1. Quarterly sales grew 4.5 percent year-over year, according to a news release.
2. Medtronic’s neuroscience business grew 4.9 percent year-over-year with $2.2 billion in sales. Factors include growth for the Mazor spine robot and StealthStation navigation system.
3. The neuromodulation segment saw mid-single digit growth with strength in the Percept and Intellis devices.
4. Medtronic raised its guidance for fiscal year 2024 and expects full-year revenue growth of 4.5 percent.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
